Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Mounjaro is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes and weight management in adults with obesity or overweight with comorbidities
Ozempic, Wegovy, and Mounjaro all belong to a group of injectable medicines
GLP-1 medications require extensive research, clinical trials and specialised manufacturing processes
Most adverse effects associated with tirzepatide are mild to moderate in severity and tend to improve with continued use as the body adapts to the medication
US$ 22.58
US$ 23.08
US$ 25.60
US$ 29.43
